Hung‐Ming Wang

6.6k total citations
88 papers, 2.4k citations indexed

About

Hung‐Ming Wang is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hung‐Ming Wang has authored 88 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 27 papers in Otorhinolaryngology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hung‐Ming Wang's work include Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (9 papers) and Palliative Care and End-of-Life Issues (9 papers). Hung‐Ming Wang is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (9 papers) and Palliative Care and End-of-Life Issues (9 papers). Hung‐Ming Wang collaborates with scholars based in Taiwan, United States and Singapore. Hung‐Ming Wang's co-authors include Chun‐Ta Liao, Shiang‐Fu Huang, Chung‐Jan Kang, Shu‐Hang Ng, Jen‐Shi Chen, Tzu‐Chen Yen, I‐How Chen, Sheng-Chieh Chan, Joseph Tung‐Chieh Chang and Ling‐Ling Hsieh and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Hung‐Ming Wang

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hung‐Ming Wang Taiwan	28	996	864	626	537	442	88	2.4k
Juan Jesús Cruz Spain	27	1.0k 1.0×	608 0.7×	505 0.8×	667 1.2×	638 1.4×	185	2.5k
Moni Abraham Kuriakose India	37	905 0.9×	1.5k 1.8×	1.4k 2.2×	794 1.5×	556 1.3×	204	4.0k
Chien‐Yu Lin Taiwan	31	969 1.0×	1.4k 1.7×	946 1.5×	373 0.7×	700 1.6×	143	2.8k
Sadhana Kannan India	24	512 0.5×	678 0.8×	509 0.8×	694 1.3×	780 1.8×	145	2.6k
Shrujal S. Baxi United States	28	1.6k 1.6×	825 1.0×	775 1.2×	309 0.6×	769 1.7×	107	2.7k
Christian Simon Switzerland	25	564 0.6×	784 0.9×	1.2k 1.9×	339 0.6×	450 1.0×	135	2.3k
Joseph Curry United States	32	1.1k 1.1×	599 0.7×	1.2k 1.9×	1.1k 2.1×	636 1.4×	238	3.6k
Gang Wu China	25	813 0.8×	454 0.5×	514 0.8×	624 1.2×	982 2.2×	170	3.1k
Jesper Grau Eriksen Denmark	36	1.0k 1.0×	1.6k 1.9×	1.0k 1.6×	570 1.1×	1.1k 2.6×	158	4.3k
Amit Joshi India	23	1.0k 1.0×	486 0.6×	562 0.9×	366 0.7×	1.1k 2.6×	233	2.3k

Countries citing papers authored by Hung‐Ming Wang

Since Specialization

Citations

This map shows the geographic impact of Hung‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Ming Wang more than expected).

Fields of papers citing papers by Hung‐Ming Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Ming Wang. The network helps show where Hung‐Ming Wang may publish in the future.

Co-authorship network of co-authors of Hung‐Ming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Ming Wang. A scholar is included among the top collaborators of Hung‐Ming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Ming Wang. Hung‐Ming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Chao‐Wei, Shin‐Cheh Chen, Po‐Nan Wang, et al.. (2024). Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan. Hepatology International. 18(2). 449–460. 2 indexed citations

Razak, Albiruni Ryan Abdul, Hung‐Ming Wang, Jang‐Yang Chang, et al.. (2023). A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Targeted Oncology. 18(6). 853–868. 10 indexed citations

Li, Hsin‐Pai, Chen‐Yang Huang, Kar‐Wai Lui, et al.. (2023). Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways. Translational Oncology. 38. 101785–101785. 3 indexed citations

Wang, Tsae‐Jyy, et al.. (2022). Effect of Oral Exercise on Trismus after Oral Cancer Radiotherapy: A Quasi-Experimental Study. Biomedicines. 10(11). 2951–2951. 3 indexed citations

Siow, Tiing Yee, Chih‐Hua Yeh, Gigin Lin, et al.. (2022). MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy. Cancers. 14(24). 6119–6119. 8 indexed citations

Chou, Yung‐Chih, Kang‐Hsing Fan, Chien‐Yu Lin, et al.. (2021). Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study. Cancers. 13(14). 3555–3555. 21 indexed citations

Li, Hsin‐Pai, Chen‐Yang Huang, Kar‐Wai Lui, et al.. (2021). Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment. Cancers. 13(12). 2954–2954. 11 indexed citations

Liao, Chun‐Ta, Lan‐Yan Yang, Li‐Yu Lee, et al.. (2021). Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma. Oral Oncology. 122. 105547–105547. 6 indexed citations

Chien, Huei‐Tzu, Sou‐De Cheng, Chun‐Ta Liao, Hung‐Ming Wang, & Shiang‐Fu Huang. (2019). Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas. Cancers. 11(6). 760–760. 28 indexed citations

10.

Hung, Yu‐Shin, Chia‐Yen Hung, Chaohui Wang, et al.. (2017). Clinical characteristics and survival outcomes of terminally ill patients undergoing withdrawal of mechanical ventilation. Journal of the Formosan Medical Association. 117(9). 798–805. 8 indexed citations

11.

Su, Po‐Jung, Min‐Hsien Wu, Hung‐Ming Wang, et al.. (2016). Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy. Scientific Reports. 6(1). 31423–31423. 35 indexed citations

12.

Shen, Wen‐Chi, Chen‐Yi Kao, Hung‐Ming Wang, et al.. (2016). Impact of Palliative Care Consultation Service on Terminally Ill Cancer Patients. Medicine. 95(10). e2981–e2981. 16 indexed citations

13.

Wang, Hung‐Ming, Hsien‐Kun Chang, Chia‐Hsun Hsieh, et al.. (2013). Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomedical Journal. 36(5). 229–229. 10 indexed citations

14.

Huang, Shiang‐Fu, et al.. (2013). Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations. PLoS ONE. 8(6). e65578–e65578. 19 indexed citations

15.

Liu, Tsang‐Wu, et al.. (2012). Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001–2006. Acta Oncologica. 51(4). 505–511. 22 indexed citations

16.

Huang, Kuo-Hao, Shiang‐Fu Huang, I‐How Chen, et al.. (2009). Methylation of RASSF1A, RASSF2A , and HIN-1 Is Associated with Poor Outcome after Radiotherapy, but not Surgery, in Oral Squamous Cell Carcinoma. Clinical Cancer Research. 15(12). 4174–4180. 63 indexed citations

17.

Li, Yingying, Wen‐Chi Chou, Chuang‐Chi Liaw, et al.. (2007). Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers. Lung Cancer. 59(2). 180–191. 56 indexed citations

18.

Liao, Chun‐Ta, Joseph Tung‐Chieh Chang, Hung‐Ming Wang, et al.. (2006). Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer. 107(2). 337–344. 113 indexed citations

19.

Lin, Yung‐Chang, et al.. (2000). Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma. Cancer. 89(4). 750–756. 100 indexed citations

20.

Chen, Jen‐Shi, Yi-Yin Jan, Yung‐Chang Lin, et al.. (1998). Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anti-Cancer Drugs. 9(5). 393–397. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact